Evidence map›Paper›PMID 27601642›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

TRiC subunits enhance BDNF axonal transport and rescue striatal atrophy in Huntington's disease.

Xiaobei Zhao, Xu-Qiao Chen, Eugene Han, Yue Hu, Paul Paik, Zhiyong Ding, Julia Overman, Alice L Lau, Sarah H Shahmoradian, Wah Chiu and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 97 citations in OpenAlex.

  1. Review
  2. Article
  3. Chaperonin in health and disease.Molecular biomedicine · 2026
    Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Xiaobei ZhaoDepartment of Neurosciences, University of California, San Diego, La Jolla, CA 92093;
Xu-Qiao ChenDepartment of Neurosciences, University of California, San Diego, La Jolla, CA 92093;
Eugene HanDepartment of Neurosciences, University of California, San Diego, La Jolla, CA 92093;
Yue HuDepartment of Neurosciences, University of California, San Diego, La Jolla, CA 92093;
Paul PaikDepartment of Neurosciences, University of California, San Diego, La Jolla, CA 92093;
Zhiyong DingThe University of Texas M. D. Anderson Cancer Center, Houston, TX 77054;
Julia OvermanDepartment of Neurobiology and Behavior, University of California, Irvine, CA 92697;
Alice L LauDepartment of Neurobiology and Behavior, University of California, Irvine, CA 92697;
Sarah H ShahmoradianNational Center for Macromolecular Imaging, Verna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, TX 77030;
Wah ChiuNational Center for Macromolecular Imaging, Verna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, TX 77030;
Leslie M ThompsonDepartment of Neurobiology and Behavior, University of California, Irvine, CA 92697; Department of Psychiatry and Human Behavior, University of California, Irvine, CA 92697.
Chengbiao WuDepartment of Neurosciences, University of California, San Diego, La Jolla, CA 92093; chw049@ucsd.edu wmobley@ucsd.edu.
William C MobleyDepartment of Neurosciences, University of California, San Diego, La Jolla, CA 92093; chw049@ucsd.edu wmobley@ucsd.edu.
University of California, San Diego · USUniversity of California, Irvine · USBaylor College of Medicine · USThe University of Texas MD Anderson Cancer Center · US

Funding

Center for Protein Folding Machinery (RMI)PN2EY016525 · NEI · BAYLOR COLLEGE OF MEDICINE · PI CHIU, WAH · 2005 to 2015
$33.6M
3 D ELECTRON MICROSCOPY OF MACROMOLECULES (5P41RR002250-27)P41GM103832 · NIGMS · STANFORD UNIVERSITY · PI CHIU, WAH · 2012 to 2019
$15.1M
Project 3: TRiC modulation of CNS pathogenesis in HD mouse modelsP01NS092525 · NINDS · UNIVERSITY OF CALIFORNIA-IRVINE · PI THOMPSON, LESLIE MICHELS · 2016 to 2020
$6.3M
Training Program in Stem Cell Translational Medicine for Neurological DisordersT32NS082174 · NINDS · UNIVERSITY OF CALIFORNIA-IRVINE · PI PETER John DONOVAN, Leslie Michels Thompson · 2013 to 2026
$3.3M
Nanobiology Interdisciplinary Graduate Training ProgramT32EB009379 · NIBIB · RICE UNIVERSITY · PI DREZEK, REBEKAH A. · 2009 to 2013
$1.6M
NEI NIH HHS PN2 EY016525NIBIB NIH HHS T32 EB009379NIGMS NIH HHS P41 GM103832NINDS NIH HHS P01 NS092525NINDS NIH HHS T32 NS082174
6 · The paper itself

Abstract

Corticostriatal atrophy is a cardinal manifestation of Huntington's disease (HD). However, the mechanism(s) by which mutant huntingtin (mHTT) protein contributes to the degeneration of the corticostriatal circuit is not well understood. We recreated the corticostriatal circuit in microfluidic chambers, pairing cortical and striatal neurons from the BACHD model of HD and its WT control. There were reduced synaptic connectivity and atrophy of striatal neurons in cultures in which BACHD cortical and striatal neurons were paired. However, these changes were prevented if WT cortical neurons were paired with BACHD striatal neurons; synthesis and release of brain-derived neurotrophic factor (BDNF) from WT cortical axons were responsible. Consistent with these findings, there was a marked reduction in anterograde transport of BDNF in BACHD cortical neurons. Subunits of the cytosolic chaperonin T-complex 1 (TCP-1) ring complex (TRiC or CCT for chaperonin containing TCP-1) have been shown to reduce mHTT levels. Both CCT3 and the apical domain of CCT1 (ApiCCT1) decreased the level of mHTT in BACHD cortical neurons. In cortical axons, they normalized anterograde BDNF transport, restored retrograde BDNF transport, and normalized lysosomal transport. Importantly, treating BACHD cortical neurons with ApiCCT1 prevented BACHD striatal neuronal atrophy by enhancing release of BDNF that subsequently acts through tyrosine receptor kinase B (TrkB) receptor on striatal neurons. Our findings are evidence that TRiC reagent-mediated reductions in mHTT enhanced BDNF delivery to restore the trophic status of BACHD striatal neurons.

Indexed as

AnimalsAtrophyBrain-Derived Neurotrophic FactorChaperonin Containing TCP-1Corpus StriatumDisease Models, AnimalHumansHuntingtin ProteinHuntington DiseaseLab-On-A-Chip DevicesMiceMutationNeuronsReceptor, trkBSpinocerebellar DegenerationsBrain-Derived Neurotrophic FactorChaperonin Containing TCP-1Huntingtin ProteinReceptor, trkBBACHD mouse modelBDNF transportHuntington’s diseasestriatal atrophyTRiC chaperonin

Identifiers

PMID27601642
PMCPMC5035849
OpenAlexW2516752397

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.